Skip to search formSkip to main contentSkip to account menu

Administration, Intravaginal

Known as: Administrations, Vaginal, Vaginal Administrations, Vaginal Administration 
The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries… 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

Instillation, Vaginal
Vaginal AbsorptionVaginal Creams, Foams, and Jellies

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Proposed Design of a Dissolution Apparatus for Vaginal Formulations Containing Probiotics
In the pharmaceutical industry, dissolution testing is a very important tool in drug development and quality control. There is a… 
2002
2002
Posterior intravaginal sling-plasty (infracoccygeal sacropexy) for severe post-hysterectomy vaginal vault prolapse-a preliminary report on efficacy and safety. Int. Urogynecol
2001
2001
Intravaginal toxicity studies of a gel-microemulsion formulation of spermicidal vanadocenes in rabbits.
Bis-cyclopentadienyl complexes of vanadium(IV) or vanadocenes are rapid and potent inhibitors of human sperm motility with… 
1987
1987
Vaginal Prostaglandin E1 Analogue (ONO‐802) to Soften the Cervix in First Trimester Abortion
Cervical softening by vaginal administration of a prostaglandin E1 analogue (ONO-802) was studies in a double-bline, placebo… 
1984
1984
Vaginal absorption of a potent luteinizing hormone-releasing hormone analogue (leuprolide) in rats. IV: Evaluation of the vaginal absorption and gonadotropin responses by radioimmunoassay.
The vaginal absorption of leuprolide (a potent luteinizing hormone-releasing hormone analogue), which has the potential for… 
1983
1983
Regression of rat mammary tumors by a potent luteinizing hormone-releasing hormone analogue (leuprolide) administered vaginally.
Potent luteinizing hormone-releasing hormone analogues are known to cause regression of hormone-dependent mammary tumors. We have… 
1981
1981
Oral versus vaginal absorption in oestradiol in postmenopausal women. Effects of different particles sizes.
Crystalline oestradiol-17 beta is poorly absorbed from the gastrointestinal tract. Three different fractions and a standard… 
1976
1976
Induction of first and second trimester abortion by the vaginal administration of 15-methyl-PGF2alpha methyl ester.
1976
1976
Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
15-methyl PGF2alpha methyl ester in a slow releasing vaginal device was administered to 30 women in the first and second… 
1974
1974
Retention of intravaginal sponge pessaries by cattle
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)